tiprankstipranks
Trending News
More News >
Xlife Sciences Ltd. (CH:XLS)
:XLS
Switzerland Market

Compare Xlife Sciences Ltd. (XLS) vs. Competitors

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Xlife Sciences Ltd.
CHF25.30
CHF148.23M
4.70
-3.80%
Molecular Partners AG
$3.50
$170.24M
-1.83
-29.08%
0 Buy
1 Hold
0 Sell
Hold
Idorsia Ltd
CHF3.74
CHF922.59M
-5.60
418.70%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
$9.36
$759.03M
6.81
0.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
$13.25
$242.81M
-2.24
40.66%
1 Buy
0 Hold
0 Sell
Moderate Buy
RELIEF THERAPEUTICS Holding
$1.88
$290.89M
-1.17
-43.04%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:XLS
Xlife Sciences Ltd.
25.30
-0.40
-1.56%
MLLCF
Molecular Partners AG
3.50
-1.01
-22.39%
CH:IDIA
Idorsia Ltd
3.75
2.98
392.12%
NWPHF
Newron Pharmaceuticals SpA
9.36
0.00
0.00%
SPHDF
Santhera Pharmaceuticals Holding
13.25
3.83
40.66%
RLFTF
RELIEF THERAPEUTICS Holding
2.42
-1.89
-43.85%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts